BIIB

Biogen Inc.

Performance

Today’s LowNA
    Today’s HighNA
    52W LowNA
      52W HighNA
      Open PricePrev. CloseVolumeAvg. Volume
      NANANANA

      Company Statistics

      Market CapP/B RatioP/E RatioEnterprise Value
      $40.78 B3.808.00$46.39 B
      Div. YieldBook ValueEPS(TTM)ROE
      NA68.574.47NA

      About the Company

      Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for t
      Organisation
      Biogen Inc.
      Industry
      Drug Manufacturers—General
      Headquarters
      Cambridge, MA
      ABOUT GROWW
      keyboard_arrow_down